![WZR WZR](https://data.pdbj.org/pdbjplus/data/cc/svg/WZR.svg) | WZR | Name: | (4~{R})-7-oxidanyl-4-phenyl-3,4-dihydro-1~{H}-quinolin-2-one | Formula: | C15 H13 N O2 | SMILES: | Oc1ccc2[CH](CC(=O)Nc2c1)c3ccccc3 | InChi: | InChI=1S/C15H13NO2/c17-11-6-7-12-13(10-4-2-1-3-5-10)9-15(18)16-14(12)8-11/h1-8,13,17H,9H2,(H,16,18)/t13-/m1/s1 | Definition date: | 2023-10-17 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | (4~{R})-7-oxidanyl-4-phenyl-3,4-dihydro-1~{H}-quinolin-2-one |
|
![XWA XWA](https://data.pdbj.org/pdbjplus/data/cc/svg/XWA.svg) | XWA | Name: | 1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-[6-[[4-(4-methylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]urea | Formula: | C32 H37 N7 O3 | SMILES: | COc1ccc(N(C(=O)Nc2c(C)cccc2C)c3cc(Nc4ccc(cc4)N5CCN(C)CC5)ncn3)c(OC)c1 | InChi: | InChI=1S/C32H37N7O3/c1-22-7-6-8-23(2)31(22)36-32(40)39(27-14-13-26(41-4)19-28(27)42-5)30-20-29(33-21-34-30)35-24-9-11-25(12-10-24)38-17-15-37(3)16-18-38/h6-14,19-21H,15-18H2,1-5H3,(H,36,40)(H,33,34,35) | Definition date: | 2023-11-14 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-[6-[[4-(4-methylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]urea |
|
![UPO UPO](https://data.pdbj.org/pdbjplus/data/cc/svg/UPO.svg) | UPO | Name: | 4-(6,7-dimethoxy-3,4-dihydro-1~{H}-isoquinolin-2-yl)-6-(3-methoxyphenyl)pyrimidin-2-amine | Formula: | C22 H24 N4 O3 | SMILES: | COc1cccc(c1)c2cc(nc(N)n2)N3CCc4cc(OC)c(OC)cc4C3 | InChi: | InChI=1S/C22H24N4O3/c1-27-17-6-4-5-15(9-17)18-12-21(25-22(23)24-18)26-8-7-14-10-19(28-2)20(29-3)11-16(14)13-26/h4-6,9-12H,7-8,13H2,1-3H3,(H2,23,24,25) | Definition date: | 2023-06-14 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 4-(6,7-dimethoxy-3,4-dihydro-1~{H}-isoquinolin-2-yl)-6-(3-methoxyphenyl)pyrimidin-2-amine |
|
![WZX WZX](https://data.pdbj.org/pdbjplus/data/cc/svg/WZX.svg) | WZX | Name: | ethyl 2-(3-oxidanylidene-2,4-dihydroquinoxalin-1-yl)ethanoate | Formula: | C12 H14 N2 O3 | SMILES: | CCOC(=O)CN1CC(=O)Nc2ccccc12 | InChi: | InChI=1S/C12H14N2O3/c1-2-17-12(16)8-14-7-11(15)13-9-5-3-4-6-10(9)14/h3-6H,2,7-8H2,1H3,(H,13,15) | Definition date: | 2023-10-17 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | ethyl 2-(3-oxidanylidene-2,4-dihydroquinoxalin-1-yl)ethanoate |
|
![X0H X0H](https://data.pdbj.org/pdbjplus/data/cc/svg/X0H.svg) | X0H | Name: | methyl 2-(2-oxidanylidene-1~{H}-quinolin-4-yl)ethanoate | Formula: | C12 H11 N O3 | SMILES: | COC(=O)CC1=CC(=O)Nc2ccccc12 | InChi: | InChI=1S/C12H11NO3/c1-16-12(15)7-8-6-11(14)13-10-5-3-2-4-9(8)10/h2-6H,7H2,1H3,(H,13,14) | Definition date: | 2023-10-17 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | methyl 2-(2-oxidanylidene-1~{H}-quinolin-4-yl)ethanoate |
|
![X0L X0L](https://data.pdbj.org/pdbjplus/data/cc/svg/X0L.svg) | X0L | Name: | 4-[(4-methylphenyl)methyl]-1~{H}-quinoxaline-2,3-dione | Formula: | C16 H14 N2 O2 | SMILES: | Cc1ccc(CN2C(=O)C(=O)Nc3ccccc23)cc1 | InChi: | InChI=1S/C16H14N2O2/c1-11-6-8-12(9-7-11)10-18-14-5-3-2-4-13(14)17-15(19)16(18)20/h2-9H,10H2,1H3,(H,17,19) | Definition date: | 2023-10-17 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 4-[(4-methylphenyl)methyl]-1~{H}-quinoxaline-2,3-dione |
|
![VLR VLR](https://data.pdbj.org/pdbjplus/data/cc/svg/VLR.svg) | VLR | Name: | 3-{2,16-dioxo-20-[(3aS,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-2-{(E)-[6-(4-methoxyphenyl)-1-methylquinolin-4(1H)-ylidene]methyl}-1,3-benzothiazol-3-ium | Formula: | C45 H55 N6 O7 S2 | SMILES: | O=C1NC2C(CCCCC(=O)NCCOCCOCCOCCNC(=O)C[n+]3c4ccccc4sc3/C=C3C=CN(C)c4ccc(cc43)c3ccc(OC)cc3)SCC2N1 | InChi: | InChI=1S/C45H54N6O7S2/c1-50-20-17-33(35-27-32(13-16-37(35)50)31-11-14-34(55-2)15-12-31)28-43-51(38-7-3-4-8-39(38)60-43)29-42(53)47-19-22-57-24-26-58-25-23-56-21-18-46-41(52)10-6-5-9-40-44-36(30-59-40)48-45(54)49-44/h3-4,7-8,11-17,20,27-28,36,40,44H,5-6,9-10,18-19,21-26,29-30H2,1-2H3,(H3-,46,47,48,49,52,53,54)/p+1/t36-,40-,44+/m1/s1 | Definition date: | 2023-09-13 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 3-{2,16-dioxo-20-[(3aS,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-2-{(E)-[6-(4-methoxyphenyl)-1-methylquinolin-4(1H)-ylidene]methyl}-1,3-benzothiazol-3-ium |
|
![XFZ XFZ](https://data.pdbj.org/pdbjplus/data/cc/svg/XFZ.svg) | XFZ | Name: | Bis-1,3-phenyl guanylhydrazon | Formula: | C10 H14 N8 | SMILES: | NC(N)=NN=Cc1cccc(C=NN=C(N)N)c1 | InChi: | InChI=1S/C10H14N8/c11-9(12)17-15-5-7-2-1-3-8(4-7)6-16-18-10(13)14/h1-6H,(H4,11,12,17)(H4,13,14,18)/b15-5+,16-6+ | Synonyms: | 2-[(E)-[3-[(E)-[bis(azanyl)methylidenehydrazinylidene]methyl]phenyl]methylideneamino]guanidine | Definition date: | 2023-11-01 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 2-[(~{E})-[3-[(~{E})-[bis(azanyl)methylidenehydrazinylidene]methyl]phenyl]methylideneamino]guanidine |
|
![VMD VMD](https://data.pdbj.org/pdbjplus/data/cc/svg/VMD.svg) | VMD | Name: | 4-[[1-[3-[[(2~{R})-2-oxidanyl-2-[(4~{S},5~{R})-2,2,5-trimethyl-1,3-dioxolan-4-yl]ethyl]amino]propyl]-1,2,3-triazol-4-yl]methylamino]benzenesulfonamide | Formula: | C20 H32 N6 O5 S | SMILES: | C[CH]1OC(C)(C)O[CH]1[CH](O)CNCCCn2cc(CNc3ccc(cc3)[S](N)(=O)=O)nn2 | InChi: | InChI=1S/C20H32N6O5S/c1-14-19(31-20(2,3)30-14)18(27)12-22-9-4-10-26-13-16(24-25-26)11-23-15-5-7-17(8-6-15)32(21,28)29/h5-8,13-14,18-19,22-23,27H,4,9-12H2,1-3H3,(H2,21,28,29)/t14-,18-,19-/m1/s1 | Definition date: | 2023-03-20 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 4-[[1-[3-[[(2~{R})-2-oxidanyl-2-[(4~{S},5~{R})-2,2,5-trimethyl-1,3-dioxolan-4-yl]ethyl]amino]propyl]-1,2,3-triazol-4-yl]methylamino]benzenesulfonamide |
|
![ZJZ ZJZ](https://data.pdbj.org/pdbjplus/data/cc/svg/ZJZ.svg) | ZJZ | Name: | 7-(2-azanyl-5-chloranyl-phenyl)-3$l^{3}-thia-5,6$l^{4}-diaza-2$l^{3}-platinatricyclo[6.4.0.0^{2,6}]dodeca-1(12),3,6,8,10-pentaen-4-amine | Formula: | C14 H12 Cl N4 Pt S | SMILES: | NC(=S)NN=C(c1cc(Cl)ccc1N)c2ccccc2[Pt] | InChi: | InChI=1S/C14H12ClN4S.Pt/c15-10-6-7-12(16)11(8-10)13(18-19-14(17)20)9-4-2-1-3-5-9 | Definition date: | 2023-04-01 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 7-(2-azanyl-5-chloranyl-phenyl)-3$l^{3}-thia-5,6$l^{4}-diaza-2$l^{3}-platinatricyclo[6.4.0.0^{2,6}]dodeca-1(12),3,6,8,10-pentaen-4-amine |
|
![SRF SRF](https://data.pdbj.org/pdbjplus/data/cc/svg/SRF.svg) | SRF | Name: | (1~{S},3~{Z})-3-[(2~{E})-2-[(1~{R},3~{a}~{S},7~{a}~{R})-1-[(2~{R})-5,5-bis(fluoranyl)-6-methyl-6-oxidanyl-heptan-2-yl]-7~{a}-methyl-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol | Formula: | C27 H42 F2 O2 | SMILES: | C[CH](CCC(F)(F)C(C)(C)O)[CH]1CC[CH]2C(CCC[C]12C)=CC=C3C[CH](O)CCC3=C | InChi: | InChI=1S/C27H42F2O2/c1-18-8-11-22(30)17-21(18)10-9-20-7-6-15-26(5)23(12-13-24(20)26)19(2)14-16-27(28,29)25(3,4)31/h9-10,19,22-24,30-31H,1,6-8,11-17H2,2-5H3/b20-9+,21-10-/t19-,22+,23-,24+,26-/m1/s1 | Definition date: | 2023-04-13 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | (1~{S},3~{Z})-3-[(2~{E})-2-[(1~{R},3~{a}~{S},7~{a}~{R})-1-[(2~{R})-5,5-bis(fluoranyl)-6-methyl-6-oxidanyl-heptan-2-yl]-7~{a}-methyl-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol |
|
![VN9 VN9](https://data.pdbj.org/pdbjplus/data/cc/svg/VN9.svg) | VN9 | Name: | 3,4-dihydro-1~{H}-quinolin-2-one | Formula: | C9 H9 N O | SMILES: | O=C1CCc2ccccc2N1 | InChi: | InChI=1S/C9H9NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-4H,5-6H2,(H,10,11) | Definition date: | 2023-03-20 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 3,4-dihydro-1~{H}-quinolin-2-one |
|
![VNE VNE](https://data.pdbj.org/pdbjplus/data/cc/svg/VNE.svg) | VNE | Name: | (3-methoxyphenyl)-pyrrol-1-yl-methanone | Formula: | C12 H11 N O2 | SMILES: | COc1cccc(c1)C(=O)n2cccc2 | InChi: | InChI=1S/C12H11NO2/c1-15-11-6-4-5-10(9-11)12(14)13-7-2-3-8-13/h2-9H,1H3 | Definition date: | 2023-03-20 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | (3-methoxyphenyl)-pyrrol-1-yl-methanone |
|
![USI USI](https://data.pdbj.org/pdbjplus/data/cc/svg/USI.svg) | USI | Name: | ~{N}4-(1~{H}-indol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine | Formula: | C20 H19 N5 O | SMILES: | COc1cccc(c1)c2cc(NCc3ccc4[nH]ccc4c3)nc(N)n2 | InChi: | InChI=1S/C20H19N5O/c1-26-16-4-2-3-14(10-16)18-11-19(25-20(21)24-18)23-12-13-5-6-17-15(9-13)7-8-22-17/h2-11,22H,12H2,1H3,(H3,21,23,24,25) | Definition date: | 2023-06-18 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | ~{N}4-(1~{H}-indol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine |
|
![VNO VNO](https://data.pdbj.org/pdbjplus/data/cc/svg/VNO.svg) | VNO | Name: | 1-(2-ethylsulfonylethyl)-1,3,3-trimethyl-urea | Formula: | C8 H18 N2 O3 S | SMILES: | CC[S](=O)(=O)CCN(C)C(=O)N(C)C | InChi: | InChI=1S/C8H18N2O3S/c1-5-14(12,13)7-6-10(4)8(11)9(2)3/h5-7H2,1-4H3 | Definition date: | 2023-03-20 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 1-(2-ethylsulfonylethyl)-1,3,3-trimethyl-urea |
|
![VNV VNV](https://data.pdbj.org/pdbjplus/data/cc/svg/VNV.svg) | VNV | Name: | 3-phenyl-1,2-oxazol-5-amine | Formula: | C9 H8 N2 O | SMILES: | Nc1onc(c1)c2ccccc2 | InChi: | InChI=1S/C9H8N2O/c10-9-6-8(11-12-9)7-4-2-1-3-5-7/h1-6H,10H2 | Definition date: | 2023-03-20 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 3-phenyl-1,2-oxazol-5-amine |
|
![W6F W6F](https://data.pdbj.org/pdbjplus/data/cc/svg/W6F.svg) | W6F | Name: | 2-[(E)-(1,7-dimethylquinolin-4(1H)-ylidene)methyl]-3-{2,16-dioxo-20-[(3aR,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-1,3-benzothiazol-3-ium | Formula: | C39 H51 N6 O6 S2 | SMILES: | O=C1NC2C(CCCCC(=O)NCCOCCOCCOCCNC(=O)C[n+]3c4ccccc4sc3/C=C3C=CN(C)c4cc(C)ccc43)SCC2N1 | InChi: | InChI=1S/C39H50N6O6S2/c1-27-11-12-29-28(13-16-44(2)32(29)23-27)24-37-45(31-7-3-4-8-33(31)53-37)25-36(47)41-15-18-50-20-22-51-21-19-49-17-14-40-35(46)10-6-5-9-34-38-30(26-52-34)42-39(48)43-38/h3-4,7-8,11-13,16,23-24,30,34,38H,5-6,9-10,14-15,17-22,25-26H2,1-2H3,(H3-,40,41,42,43,46,47,48)/p+1/t30-,34-,38?/m0/s1 | Definition date: | 2023-09-25 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 2-[(E)-(1,7-dimethylquinolin-4(1H)-ylidene)methyl]-3-{2,16-dioxo-20-[(3aR,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-1,3-benzothiazol-3-ium |
|
![SV0 SV0](https://data.pdbj.org/pdbjplus/data/cc/svg/SV0.svg) | SV0 | Name: | (1~{S},3~{Z})-3-[(2~{E})-2-[(1~{R},3~{a}~{S},7~{a}~{R})-1-[(2~{R},4~{R})-4-fluoranyl-6-methyl-6-oxidanyl-heptan-2-yl]-7~{a}-methyl-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol | Formula: | C27 H43 F O2 | SMILES: | C[CH](C[CH](F)CC(C)(C)O)[CH]1CC[CH]2C(CCC[C]12C)=CC=C3C[CH](O)CCC3=C | InChi: | InChI=1S/C27H43FO2/c1-18-8-11-23(29)16-21(18)10-9-20-7-6-14-27(5)24(12-13-25(20)27)19(2)15-22(28)17-26(3,4)30/h9-10,19,22-25,29-30H,1,6-8,11-17H2,2-5H3/b20-9+,21-10-/t19-,22-,23+,24-,25+,27-/m1/s1 | Definition date: | 2023-04-13 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | (1~{S},3~{Z})-3-[(2~{E})-2-[(1~{R},3~{a}~{S},7~{a}~{R})-1-[(2~{R},4~{R})-4-fluoranyl-6-methyl-6-oxidanyl-heptan-2-yl]-7~{a}-methyl-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol |
|
![W8U W8U](https://data.pdbj.org/pdbjplus/data/cc/svg/W8U.svg) | W8U | Name: | (4M)-4-{(4S)-3-[(2-chloropyridin-3-yl)methyl][1,2,4]triazolo[4,3-a]pyridin-7-yl}-N-(oxan-4-yl)pyrimidin-2-amine | Formula: | C21 H20 Cl N7 O | SMILES: | Clc1ncccc1Cc1nnc2cc(ccn21)c1nc(ncc1)NC1CCOCC1 | InChi: | InChI=1S/C21H20ClN7O/c22-20-15(2-1-7-23-20)13-19-28-27-18-12-14(4-9-29(18)19)17-3-8-24-21(26-17)25-16-5-10-30-11-6-16/h1-4,7-9,12,16H,5-6,10-11,13H2,(H,24,25,26) | Definition date: | 2023-09-27 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | (4M)-4-{(4S)-3-[(2-chloropyridin-3-yl)methyl][1,2,4]triazolo[4,3-a]pyridin-7-yl}-N-(oxan-4-yl)pyrimidin-2-amine |
|
![UKI UKI](https://data.pdbj.org/pdbjplus/data/cc/svg/UKI.svg) | UKI | Name: | N-(2-(dimethylamino)ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulfonamide | Formula: | C24 H28 N6 O3 S | SMILES: | CN(C)CCN[S](=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4[nH]c(C)cc4c3)n2)c1 | InChi: | InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29) | Synonyms: | Sulfatinib | Definition date: | 2023-06-08 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | ~{N}-[2-(dimethylamino)ethyl]-1-[3-[[4-[(2-methyl-1~{H}-indol-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]methanesulfonamide |
|
![SXP SXP](https://data.pdbj.org/pdbjplus/data/cc/svg/SXP.svg) | SXP | Name: | 2-[(2S,3R,4S,5R,6R)-2-[2-[2,5-bis(chloranyl)phenyl]-5-methyl-1,2,4-triazol-3-yl]-4-[4-[4-chloranyl-3,5-bis(fluoranyl)phenyl]-1,2,3-triazol-1-yl]-6-(hydroxymethyl)-5-oxidanyl-oxan-3-yl]oxyethanoic acid | Formula: | C25 H21 Cl3 F2 N6 O6 | SMILES: | Cc1nn(c(n1)[CH]2O[CH](CO)[CH](O)[CH]([CH]2OCC(O)=O)n3cc(nn3)c4cc(F)c(Cl)c(F)c4)c5cc(Cl)ccc5Cl | InChi: | InChI=1S/C25H21Cl3F2N6O6/c1-10-31-25(36(33-10)17-6-12(26)2-3-13(17)27)24-23(41-9-19(38)39)21(22(40)18(8-37)42-24)35-7-16(32-34-35)11-4-14(29)20(28)15(30)5-11/h2-7,18,21-24,37,40H,8-9H2,1H3,(H,38,39)/t18-,21+,22+,23-,24-/m1/s1 | Definition date: | 2023-04-14 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 2-[(2~{S},3~{R},4~{S},5~{R},6~{R})-2-[2-[2,5-bis(chloranyl)phenyl]-5-methyl-1,2,4-triazol-3-yl]-4-[4-[4-chloranyl-3,5-bis(fluoranyl)phenyl]-1,2,3-triazol-1-yl]-6-(hydroxymethyl)-5-oxidanyl-oxan-3-yl]oxyethanoic acid |
|
![WAL WAL](https://data.pdbj.org/pdbjplus/data/cc/svg/WAL.svg) | WAL | Name: | (4M)-4-{(4R)-3-[(2S)-2-methylbutyl][1,2,4]triazolo[4,3-a]pyridin-7-yl}-N-(1-methyl-1H-pyrazol-5-yl)pyrimidin-2-amine | Formula: | C19 H22 N8 | SMILES: | Cn1nccc1Nc1nccc(n1)c1cc2nnc(CC(C)CC)n2cc1 | InChi: | InChI=1S/C19H22N8/c1-4-13(2)11-17-24-25-18-12-14(7-10-27(17)18)15-5-8-20-19(22-15)23-16-6-9-21-26(16)3/h5-10,12-13H,4,11H2,1-3H3,(H,20,22,23)/t13-/m0/s1 | Definition date: | 2023-09-28 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | (4M)-4-{(4R)-3-[(2S)-2-methylbutyl][1,2,4]triazolo[4,3-a]pyridin-7-yl}-N-(1-methyl-1H-pyrazol-5-yl)pyrimidin-2-amine |
|
![VFI VFI](https://data.pdbj.org/pdbjplus/data/cc/svg/VFI.svg) | VFI | Name: | 4-[8-methoxy-2-methyl-1-(1-phenylethyl)imidazo[4,5-c]quinolin-7-yl]-3,5-dimethyl-1,2-oxazole | Formula: | C25 H24 N4 O2 | SMILES: | COc1cc2c(cc1c3c(C)onc3C)ncc4nc(C)n([CH](C)c5ccccc5)c24 | InChi: | InChI=1S/C25H24N4O2/c1-14-24(16(3)31-28-14)20-11-21-19(12-23(20)30-5)25-22(13-26-21)27-17(4)29(25)15(2)18-9-7-6-8-10-18/h6-13,15H,1-5H3/t15-/m1/s1 | Definition date: | 2023-07-22 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | 4-[8-methoxy-2-methyl-1-(1-phenylethyl)imidazo[4,5-c]quinolin-7-yl]-3,5-dimethyl-1,2-oxazole |
|
![ZTO ZTO](https://data.pdbj.org/pdbjplus/data/cc/svg/ZTO.svg) | ZTO | Name: | N-(3-{[(3R)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl]methyl}phenyl)-4-methoxybenzamide | Formula: | C23 H19 F N2 O3 | SMILES: | COc1ccc(cc1)C(=O)Nc1cccc(c1)CC1c2cc(F)ccc2NC1=O | InChi: | InChI=1S/C23H19FN2O3/c1-29-18-8-5-15(6-9-18)22(27)25-17-4-2-3-14(11-17)12-20-19-13-16(24)7-10-21(19)26-23(20)28/h2-11,13,20H,12H2,1H3,(H,25,27)(H,26,28)/t20-/m1/s1 | Definition date: | 2023-03-31 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | N-(3-{[(3R)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl]methyl}phenyl)-4-methoxybenzamide |
|
![WVU WVU](https://data.pdbj.org/pdbjplus/data/cc/svg/WVU.svg) | WVU | Name: | (phenylmethyl) 3-oxidanylidenepiperazine-1-carboxylate | Formula: | C12 H14 N2 O3 | SMILES: | O=C1CN(CCN1)C(=O)OCc2ccccc2 | InChi: | InChI=1S/C12H14N2O3/c15-11-8-14(7-6-13-11)12(16)17-9-10-4-2-1-3-5-10/h1-5H,6-9H2,(H,13,15) | Definition date: | 2023-10-16 | Last modified: | 2024-03-22 | Release date: | 2024-03-27 | Identifier: | (phenylmethyl) 3-oxidanylidenepiperazine-1-carboxylate |
|